Indianapolis, IN, United States of America

Matthew Dale Hilton


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1996-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Matthew Dale Hilton

Introduction

Matthew Dale Hilton is a noted inventor based in Indianapolis, Indiana. With a strong focus on microbiology and its applications, he has made significant contributions to the field through his innovative patents. His work primarily revolves around the production of unique antimycotic lipopeptides, which have critical implications for both human and plant health.

Latest Patents

Matthew holds a total of four patents, showcasing his expertise and commitment to advancing scientific knowledge. His latest patents include:

1. **Pseudomycin production by Pseudomonas syringae**: This patent describes a method for producing one or more pseudomycins, emphasizing cultures that yield compounds with a specific lipophilic moiety characterized by the general formula (I).

2. **Pseudomycin production by Pseudomonas syringae**: This invention focuses on a family of unique antimycotic lipopeptide compounds produced by Pseudomonas syringae. These lipopeptides are effective against various human and plant fungal pathogens, notably characterized by their molecular weights of 1137, 1153, 1164, and 1181 daltons.

Career Highlights

Matthew has had a distinguished career, primarily working with Eli Lilly and Company. His dedication to research and development in the field of microbiology has solidified his reputation as an innovative thinker and a proactive contributor to scientific advancement. His work not only aids in understanding fungal pathogens but also paves the way for the development of new therapeutic strategies.

Collaborations

Matthew has collaborated with esteemed colleagues such as Paul R. Atkinson and Peter K. Lambooy. These collaborations emphasize the importance of teamwork in achieving breakthrough innovations and developing effective solutions to complex biological challenges.

Conclusion

In conclusion, Matthew Dale Hilton's contributions to the field of microbiology through his patents have had a significant impact on the understanding and treatment of fungal diseases. His work at Eli Lilly and Company and collaboration with fellow researchers demonstrate the vital role of innovation in advancing health sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…